University of Minnesota. Driven to Discover.
The plan focuses on 10 strategic priorities, including combating antimicrobial resistance.
Dangerous microbes are gaining a foothold.
Stuart Levy, MD, who years ago warned about antibiotic overuse, died last week.
More than 80% of the dogs' positive findings are in the general hospital environment.
A letter argues that the EPA has ignored other federal agencies and scientific evidence.
"The antibiotic resistance pattern of this strain is alarming," a CDC expert says.
The findings don't establish a causal relationship but show a possible connection, especially with certain antibiotics and regions of the GI tract.
Lefamulin approval was supported by two phase 3 trials involving moxifloxacin.
Postprescription audit and review showed more promise than preauthorization.
The shorter, simpler regimen with the new drug is poised to improve treatment against a difficult disease and to lower costs.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.